3t Biosciences

Overview

3T Biosciences is an immunotherapy company focused on developing next-generation therapies for solid tumors and other immune-mediated diseases. Utilizing its proprietary 3T-TRACE platform, the company identifies novel T-cell receptor targets to create specific and effective treatments.

Therapeutic areas

API / Drug Master Files

3t Biosciences holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED EXOSOMES SUBPOPULATION 1Active2025-04-27
• HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED EXOSOMES SUBPOPULATION 2Active2025-04-27

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to 3t Biosciences in our records. PharmaTek screens the full directory against live FDA enforcement data.